Literature DB >> 25421861

Nervous system lyme disease.

John J Halperin1.   

Abstract

Lyme disease, a multisystem spirochetal infection, continues to be the subject of considerable debate, but not controversy. Recent years have seen improvements in diagnostic tools, better understanding of pathophysiology, and increasing evidence of efficacy of standard treatment regimens. Nervous system involvement is particularly confusing to patients and many physicians. A rational approach based on objective findings can clarify the cause and dictate the best treatment of patients' difficulties. Diagnosis for all but the earliest cases rests on the combination of likely contact with infected Ixodes ticks and laboratory confirmation of exposure to the causative organism, Borrelia burgdorferi (two-tier serology, combining ELISA with a confirmatory Western blot). Treatment is generally with oral antimicrobials such as doxycycline. Parenteral regimens are usually necessary only for the most severe cases.

Entities:  

Year:  2015        PMID: 25421861     DOI: 10.1007/s11908-014-0445-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  45 in total

1.  Successful treatment of erythema migrans Afzelius.

Authors:  E HOLLSTROM
Journal:  Acta Derm Venereol       Date:  1951       Impact factor: 4.437

2.  Treatment of the early manifestations of Lyme disease.

Authors:  A C Steere; G J Hutchinson; D W Rahn; L H Sigal; J E Craft; E T DeSanna; S E Malawista
Journal:  Ann Intern Med       Date:  1983-07       Impact factor: 25.391

3.  Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans.

Authors:  M E Aguero-Rosenfeld; J Nowakowski; S Bittker; D Cooper; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Authors:  Gary P Wormser; Martin Schriefer; Maria E Aguero-Rosenfeld; Andrew Levin; Allen C Steere; Robert B Nadelman; John Nowakowski; Adriana Marques; Barbara J B Johnson; J Stephen Dumler
Journal:  Diagn Microbiol Infect Dis       Date:  2012-10-11       Impact factor: 2.803

Review 5.  Pseudotumor cerebri in Lyme disease: a case report and literature review.

Authors:  L Kan; S K Sood; J Maytal
Journal:  Pediatr Neurol       Date:  1998-05       Impact factor: 3.372

Review 6.  Treatment trials for post-Lyme disease symptoms revisited.

Authors:  Mark S Klempner; Phillip J Baker; Eugene D Shapiro; Adriana Marques; Raymond J Dattwyler; John J Halperin; Gary P Wormser
Journal:  Am J Med       Date:  2013-06-10       Impact factor: 4.965

7.  Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

Authors:  Volker Fingerle; Ulrike C Schulte-Spechtel; Eva Ruzic-Sabljic; Sarah Leonhard; Heidelore Hofmann; Klaus Weber; Kurt Pfister; Franc Strle; Bettina Wilske
Journal:  Int J Med Microbiol       Date:  2007-07-05       Impact factor: 3.473

8.  Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

Authors:  S Hammers-Berggren; K Hansen; A M Lebech; M Karlsson
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

9.  Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  J J Halperin; E D Shapiro; E Logigian; A L Belman; L Dotevall; G P Wormser; L Krupp; G Gronseth; C T Bever
Journal:  Neurology       Date:  2007-05-23       Impact factor: 9.910

10.  The spirochetal etiology of erythema chronicum migrans Afzelius.

Authors:  E Asbrink; B Hederstedt; A Hovmark
Journal:  Acta Derm Venereol       Date:  1984       Impact factor: 4.437

View more
  3 in total

1.  Antagonist of the neurokinin-1 receptor curbs neuroinflammation in ex vivo and in vitro models of Lyme neuroborreliosis.

Authors:  Alejandra N Martinez; Geeta Ramesh; Mary B Jacobs; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2015-12-30       Impact factor: 8.322

2.  A murine model of Lyme disease demonstrates that Borrelia burgdorferi colonizes the dura mater and induces inflammation in the central nervous system.

Authors:  Timothy Casselli; Ali Divan; Emilie E Vomhof-DeKrey; Yvonne Tourand; Heidi L Pecoraro; Catherine A Brissette
Journal:  PLoS Pathog       Date:  2021-02-01       Impact factor: 6.823

3.  Borrelia burgdorferi adhere to blood vessels in the dura mater and are associated with increased meningeal T cells during murine disseminated borreliosis.

Authors:  Ali Divan; Timothy Casselli; S Anand Narayanan; Sanjib Mukherjee; David C Zawieja; John A Watt; Catherine A Brissette; M Karen Newell-Rogers
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.